Clinical trial
Comparison of PEG-Intron and Two Different Doses of Ribavirin for the Treatment…
NCT00299936 · Weill Medical College of Cornell University, Other · Completed
Key facts
| NCT number | NCT00299936 |
|---|---|
| Title | Comparison of PEG-Intron and Two Different Doses of Ribavirin for the Treatment of Chronic Hepatitis C In Treatment Naïve Subjects |
| Official title | Comparison of PEG Interferon Alfa-2b Plus Ribavirin Given as a Fixed Dose or on a Weight Optimized Basis for Treatment of Chronic Hepatitis C in Previously Untreated Adult Subjects |
| Lead sponsor | Weill Medical College of Cornell University, Other |
| Collaborators | Schering-Plough Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C |
| Intervention type | Drug |
| Interventions | Ribavirin, PEG-Intron |
| Enrollment | 5,000 |
| First posted | Mar 7, 2006 |
| Last update posted | Mar 7, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: